Ribozyme mediated therapy for chronic myelogenous leukemia.
Leopold
L H
LH
Temple University Hospital, Philadelphia, Pennsylvania.
Shore
S K
SK
Newkirk
T
T
Mangan
K
K
Reddy
E P
EP
D001483:Base Sequence; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D016044:Fusion Proteins, bcr-abl / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D008969:Molecular Sequence Data; D016337:RNA, Catalytic / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured
D016337:RNA, Catalytic; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016044:Fusion Proteins, bcr-abl